NLRP3 and neoplasm: To determine whether IOP activation of the NLRP3 inflammasome is causally related to its anti-tumor activity, we examined the effects of NLRP3 inflammasome inhibition (using a small molecule inhibitor MCC950) or activation (transfected NLRP3 overexpressed plasmid) on the growth of SW620 cell.